Parliament Question: Medical Devices Sector

GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS LOK SABHA UNSTARRED QUESTION NO. 2340 TO BE ANSWERED ON THE 13th FEBRUARY, 2026 Medical Devices Sector †2340. Shri Rajpalsinh Mahendrasinh Jadav: Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) the specific high-end medical devices currently being manufactured in India under the Production Linked Incentive (PLI) Scheme; (b) the manner in which Medical Device Parks are assisting manufacturers in achieving economies of scale in production; (c) whether high-tech manpower in the field has been developed through various Skill Development sub-schemes; and (d) if so, the details thereof along with the strategy formulated by the Government to foster and promote industry-academia collaboration in the medical devices sector? ANSWER THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SMT ANUPRIYA PATEL) (a): The Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices aims to promote domestic manufacturing of medical devices by attracting large investments for creation of domestic manufacturing capacity and incentivising domestic production. The list of high-end medical devices that are currently being manufactured in the country under the scheme is at Annexure. (b): The setting up of a Medical Device Park each in the States of Uttar Pradesh, Madhya Pradesh and Tamil Nadu, under the Scheme for Promotion of Medical Device Parks, is aimed at developing a highly competitive domestic manufacturing ecosystem by creating a state-of- the-art manufacturing ecosystem that offers plug-and-play facilities to greenfield units set up in these parks. Medical Device Parks offer land at substantially subsidised rates, often coupled with exemptions or concessions on stamp duty, which significantly reduces initial capital outlay on land acquisition and project establishment. This upfront cost relief is particularly important for greenfield investors, as it allows a larger share of their capital to be directed towards plant and machinery, technology acquisition, automation and quality systems, rather than land costs and costs of establishing facilities that are being made available as common facilities in these Parks, such as 3D design and printing, electronic assembly, electromagnetic interference and compatibility centre, moulding, sterilisation, biocompatibility testing, toxicology, electronic parts testing, component testing, gamma radiation facility. By providing such facilities on shared basis, the parks eliminate the need for individual companies to invest in expensive, capital-intensive infrastructure that is often under-utilised if set up in-house. Thissignificantly reduces the per-unit cost of manufacturing, testing and validation, while also shortening product development timelines. (c): The Capacity Building and Skill Development in Medical Device Sector sub-scheme of the Strengthening of Medical Device Industry scheme is currently in the implementation phase. Under this sub-scheme, specialised high-tech manpower is being developed through post- graduate, PG-diploma and skilling programmes in medical devices. Academic institutions under this sub scheme deliver industry-aligned curriculum with hands-on training in medical device design, production, testing and diagnostics, supported by industry exposure, internships and applied research. So far, 18 projects have been approved, covering over 12 premier institutions, including IITs, NITs, NIPERs, NIMHANS etc. serving to create about 750 high-tech professionals over the next three years. (d): The Promotion of Research in Pharma-Medtech Sector (PRIP) scheme has been launched by Department of Pharmaceuticals to provide financial assistance for research and development projects of industry, MSMEs and startups in priority areas, including novel medical devices. With a view to help build specific research capacities in medical devices, tapping industry- academia linkage, institutional strengthening of research infrastructure and nurturing of talent pool has been undertaken through the setting up of a Centre of Excellence on medical devices with advanced facilities at the National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad. Further, the NIPER Council has set up a NIPER Academia-Industry Coordination Committee as an institutional mechanism to promote strategic coordination between NIPERs and pharmaceuticals and medical devices industry by, among other things, facilitating greater synergies between NIPERs and industry and supporting research-driven growth, innovation, skilling and translation of academic research into industrial applications.Annexure Annexure referred to in reply to part (a) of the Lok Sabha Unstarred Question No. 2340, to be answered on 13.02.2026 High-end medical devices being manufactured in India under the PLI Scheme 1.Rotational Cobalt Machine 2.Linear Accelerator (LINAC) 3.Laser Ablation System 4.CT Scan 5.MRI 6.MRI Coils 7.Mammography 8.X-ray equipment 9.X- Ray including Fixed Line Frequency (LF) and High Frequency (HF) X-Ray Product 10.C-arm/ Surgical X-Ray C-Arm 11.Cath-Lab 12.PET Detector 13.Digital X-Ray Flat Pannel Detector 14.X - Ray Panels 15.Anesthesia Workstation 16.Anesthesia Unit Ventilators 17.Dialyzer 18.Dialysis Machine 19.Haemodialysis Catheter 20.Peritoneal Dialysis Kits 21.Oxygen Concentrators 22.High Flow Oxygen Devices 23.Intensive Care Ventilators 24.Emergency Ventilators 25.ECG 26.Patient Monitoring System / Patient Monitors 27.Multi-Parameter Monitor 28.Defibrillators / Automated External Defibrillators (AED 29.Bi-Phasic Defibrillators 30.Stress Test System 31.Hip Implants 32.Knee implants 33.Trauma Implants 34.PTCA Balloon Dilation Catheter / PTCA Balloon Catheter/Drug Eluting Balloons 35.Heart Valves 36.Stents/Drug Eluting Stents 37.Intravascular Lithotripsy Catheter System 38.Endocutter *****